早期诊断和治疗患有多阳性炎的eosinophilic粒状瘤病的患者
Salman H Siddiqui1, Harold Wilson-Morkeh1, Sara Monti2
1National Heart and Lung Institute, NIHR Imperial Biomedical Research Centre, Imperial College London, London, UK.
The journal of allergy and clinical immunology. In practice
|November 24, 2025
概括
带有多炎 (EGPA) 的异性粒状炎是一种罕见的血管炎. 早期诊断和针对IL-5的新生物疗法在改善结果和降低毒性方面表现有前途.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 带有多炎 (EGPA) 的埃索诺菲尔颗粒炎,或丘格-斯特劳斯综合征,是最罕见的抗中性粒细胞质抗体相关的血管炎.
- EGPA表现为喘,鼻炎,乙酸性炎症和小至中型血管瘤性血管炎.
- 由于EGPA的罕见性,多系统性和多种症状,诊断是具有挑战性的,需要采用多学科的方法.
研究的目的:
- 提供关于EGPA的诊断,病理生理学和管理的全面概述.
- 要突出与EGPA相关的诊断复杂性和治疗挑战.
- 为了说明不断变化的治疗环境,包括生物疗法的作用.
主要方法:
- 审查关于EGPA诊断和管理的现有文献.
- 分析当前的治疗策略,包括常规和生物药物.
- 展示了一个说明性的案例研究,以展示EGPA的临床过程.
主要成果:
- 传统的EGPA治疗与葡萄糖皮质类药物具有显著的长期不良影响.
- 早期诊断和量身定制的治疗对于改善临床结果和降低药物毒性至关重要.
- 针对IL-5或其受体的生物疗法代表了管理非严重复发性EGPA的范式转变.
结论:
- 对于EGPA的管理,需要采用多学科的方法和仔细的诊断评估.
- 生物疗法为治疗EGPA提供了一个有希望的新途径,可能减少对皮质类固醇的依赖.
- 迅速和量身定制的治疗,包括新的生物药物,可以显著改善EGPA患者的治疗结果.
相关概念视频
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
427
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
427
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
286
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
286
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
291
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
291
01:28Chronic Kidney Disease III: Interprofessional Care
326
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
326
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
443
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
443
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K